Skip to content
Clinical Trials – home

Clinique De L'infirmerie Protestante De Lyon

Verified siteinfo

France 3 Chemin Du Penthod, 69300 Caluire Et Cuire, France

  • 4 trials recruiting
  • Colon cancer · Adenocarcinoma of colon · Colorectal cancer
  • Adult patients

About Specializations

Clinique De L'infirmerie Protestante De Lyon in Caluire Et Cuire, France specialises in clinical trials of conditions such as Colon cancer, Adenocarcinoma of colon, Colorectal cancer, Colorectal cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatology

The medical center is at the forefront of rheumatology research, focusing on innovative treatments for rheumatoid arthritis. The center's research aims to enhance the efficacy of therapies for patients who have shown inadequate responses to previous treatments.

  • Subcutaneous administration of biologics
  • Comparative efficacy studies
  • Targeted treatment strategies

By exploring the comparative effectiveness of tocilizumab and abatacept, the center contributes to personalized treatment approaches, improving patient outcomes in complex cases of rheumatoid arthritis.

Oncology

Specializing in oncology, the center is pioneering research in the treatment of locally advanced rectal cancer, particularly in patients with microsatellite instability or mismatch repair deficiency. The focus is on developing non-invasive treatment strategies that minimize recurrence.

  • Neoadjuvant therapies
  • Short course radiotherapy
  • Watch-and-wait strategies

Through the integration of dostarlimab with radiotherapy, the center is advancing the field of cancer treatment by reducing the need for surgical interventions and enhancing the quality of life for patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
3 Chemin Du Penthod69300 Caluire Et CuireFrance
Recruiting now
4 trials
Conditions studied
10
Partner status
Verified site

More sites in Caluire Et CuireFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

12 clinical trials

Study on Adjusting Adalimumab Dosage for Patients with Rheumatoid Arthritis in Remission

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Centre Hospitalier Universitaire De Saint Etienne

Chemotherapy Dose Adjustment for Gastrointestinal Cancer Patients with DPD Deficiency Using Fluorouracil, Capecitabine, and Oxaliplatin

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Unicancer

Colon cancer

Recruiting

Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Study on FOLFOX Chemotherapy for Treating Advanced Colon Cancer in Patients Aged 70 and Older

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Fluorouracil
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Nicotine dependence

Not yet recruiting

Safety and efficacy of NFL-102 versus placebo for adults with tobacco dependence (Phase I/II)

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride Ph. Eur.

Colon cancer

Not recruiting

Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive

Study of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Groupement Des Hopitaux De L'Institut Catholique De Lille

Colorectal cancer+1

Not recruiting

Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Oxaliplatin
  • Sponsor:Fondation Franc.Cancerologie Digestive

Hepatic cancer

Not recruiting

Study on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive

Tendon disorder

Not recruiting

Study on the Safety and Effects of NGI226 Microparticles for Patients with Achilles Tendinopathy

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:NGI226
  • Sponsor:Novartis Pharma AG

Colon cancer

Not recruiting

Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Unicancer
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.